Hopp til hovedinnhold

Retinitis pigmentosa (RP)

Sist revidert:
Sist revidert av:

Definisjon:
Et sett av arvelige retinale sykdommer som er karakterisert ved degenerasjon i netthinnens staver, tapper og pigmentepitel
Forekomst: 
Prevalens ca. 1 per 4000
Symptomer:
Synstapet skjer gradvis og tiltakende, vanligvis med tidlig utvikling av nattblindhet og innsnevring av synsfeltet
Funn:
Nedsatt syn, redusert synsfelt og retinale forandringer sett med oftalmoskop
Diagnostikk:
En lang rekke tilleggsundersøkelser av øyet kan gjøres på Øyeavdeling, inklusive elektroretinogram
Behandling:
Det finnes ingen effektiv behandling
  1. Pennesi ME, Weleber RG, Yang P. Retinitis pigmentosa. BestPractice, last updated Mar 2018.
  2. Bek T, et al. Retinitis pigmentosa. Lægehåndbogen, sist oppdatert 13.09.2018.
  3. Ferrari S, Di lorio E, Barbaro V, et al. Retinitis pigmentosa: Genes and disease mechanisms. Curr Genomics 2011; 12: 238-49. doi:10.2174/138920211795860107 DOI  
  4. Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand 2002; Suppl 233: 1-34.
  5. Buch H, Vinding T, La Cour M, Appleyard M, Jensen GB and Nielsen NV. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology 2004; 111: 53-61. PubMed  
  6. Koenig R. Bardet-Biedl syndrome and Usher syndrome. Dev Ophthalmol 2003;37:126-140. PubMed  
  7. Pennings RJ, Fields RR, Huygen PL, Deutman AF, Kimberling WJ and Cremers CW. Usher syndrome type III can mimic other types of Usher syndrome. Ann Otol Rhinol Laryngol 2003; 112: 525-30. PubMed  
  8. Rivolta C, Berson EL and Dryja TP. Paternal uniparental heterodisomy with partial isodisomy of chromosome 1 in a patient with retinitis pigmentosa without hearing loss and a missense mutation in the Usher syndrome type II gene USH2A. Arch Ophthalmol 2002; 120: 1566-71. PubMed  
  9. Aller E, Najera C, Millan JM, et al. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments. Eur J Hum Genet 2004; 12: 407-10. PubMed  
  10. Astuto LM, Bork JM, Weston MD, et al. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002; 71: 262-75. PubMed  
  11. Stoetzel C, Laurier V, Faivre L, et al. BBS8 is rarely mutated in a cohort of 128 Bardet-Biedl syndrome families. J Hum Genet 2006; 51: 81-4. PubMed  
  12. Grant CA and Berson EL. Treatable forms of retinitis pigmentosa associated with systemic neurological disorders. Int Ophthalmol Clin 2001; 41: 103-10. PubMed  
  13. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006; 368: 1795-809. PubMed  
  14. Virgili G, Pierrottet C, Parmeggiani F, et al. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts. Invest Ophthalmol Vis Sci 2004; 45: 3418-24. PubMed  
  15. Lodha N, Westall CA, Brent M, Abdolell M and Heon E. A modified protocol for the assessment of visual function in patients with retinitis pigmentosa. Adv Exp Med Biol 2003; 533: 49-57. PubMed  
  16. Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 2005; 112: 1922. PubMed  
  17. Robson AG, Saihan Z, Jenkins SA, et al. Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol 2006; 90: 472-9. British Journal of Ophthalmology  
  18. Rayapudi S, Schwartz SG, Wang X, Chavis P. Vitamin A and fish oils for retinitis pigmentosa. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD008428. DOI: 10.1002/14651858.CD008428.pub2 DOI  
  19. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000; 20: 663-97. pmid:10940349 PubMed  
  20. Yokota T, Shiojiri T, Gotoda T, et al. Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol 1997; 41: 826-32. PubMed  
  21. Birch DG, Anderson JL and Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology 1999; 106: 258-68. PubMed  
  22. Grover S, Fishman GA, Anderson RJ, et al. Rate of visual field loss in retinitis pigmentosa. Ophthalmology 1997;104:460-465 PubMed  
  23. Grover S, Fishman GA, Anderson RJ, et al. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology 1999;106:1780-1785. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Johan H. Seland, professor emeritus, Universitetet i Bergen
  • Knut A. Holtedal, professor i allmennmedisin, Institutt for samfunnsmedisinske fag, Universitetet i Tromsø
  • Toke Bek, prof., overlæge, dr. med, Øjenafdelingen, Aarhus Universitetshospital (Lægehåndbogen)